{"disease":{"id":"high-degree-av-block","name":"high degree av block"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04128384","title":"Infranodal Conduction Time During TAVR as Predictor of HAVB","phase":"NA","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"University Hospital, Saarland","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}